On June 2, Samsung Epis Holdings announced the publication of its “2026 Sustainability Report,” which covers its ESG (Environmental, Social, and Governance) activities and major achievements.


This is the first sustainability report released by Samsung Epis Holdings, a bio investment holding company that was established in November last year. Since 2021, its subsidiary, Samsung Bioepis, has published its own sustainability reports.

Incheon Yeonsu-gu Samsung Bioepis Building. Samsung Bioepis

Incheon Yeonsu-gu Samsung Bioepis Building. Samsung Bioepis

View original image

The report details not only the key management achievements generated by Samsung Epis Holdings over the past year, but also the company’s performance in each area of environment, society, and governance, including the results of social value assessments. It identifies “R&D Innovation,” “Product Quality and Patient Safety,” and “Access to Medicines” as the main sustainability management challenges reflecting the characteristics of the biopharmaceutical industry, and discloses the company’s strategic responses and specific outcomes in these areas.


Additionally, the report highlights the company’s efforts to enhance trust as a listed company, such as independently operating the board of directors, strengthening the ethics and compliance management system, and transparently disclosing activities related to social responsibility.


Kim Kyung-Ah, CEO of Samsung Epis Holdings, stated, “Based on our business portfolio spanning biosimilars, new drug development, and bio platform development, as well as our ESG management, we will strive even harder for sustainable growth, to improve patients’ quality of life, and to enhance value for stakeholders.”



Meanwhile, Samsung Epis Holdings recently received an “AA” rating—placing it in the leader group—in the global ESG assessment conducted by the world-renowned investment information provider MSCI (Morgan Stanley Capital International), marking its first such evaluation since the company’s spin-off and listing.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing